A detailed history of Money Concepts Capital Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Money Concepts Capital Corp holds 25,868 shares of SRPT stock, worth $3.19 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
25,868
Previous 27,023 4.27%
Holding current value
$3.19 Million
Previous $4.27 Million 24.34%
% of portfolio
0.26%
Previous 0.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$124.33 - $156.75 $143,601 - $181,046
-1,155 Reduced 4.27%
25,868 $3.23 Million
Q2 2024

Aug 02, 2024

SELL
$113.33 - $163.85 $46,125 - $66,686
-407 Reduced 1.48%
27,023 $4.27 Million
Q1 2024

May 01, 2024

BUY
$93.7 - $141.53 $2,998 - $4,528
32 Added 0.12%
27,430 $3.55 Million
Q4 2023

Feb 12, 2024

SELL
$67.31 - $124.76 $23,020 - $42,667
-342 Reduced 1.23%
27,398 $2.64 Million
Q3 2023

Oct 31, 2023

BUY
$102.5 - $123.59 $58,630 - $70,693
572 Added 2.11%
27,740 $3.36 Million
Q2 2023

Jul 31, 2023

SELL
$106.4 - $157.19 $47,135 - $69,635
-443 Reduced 1.6%
27,168 $3.11 Million
Q1 2023

May 01, 2023

SELL
$117.53 - $155.99 $92,496 - $122,764
-787 Reduced 2.77%
27,611 $3.81 Million
Q3 2022

Oct 27, 2022

BUY
$75.71 - $119.24 $18,094 - $28,498
239 Added 0.66%
36,554 $4.04 Million
Q2 2022

Jul 18, 2022

SELL
$62.69 - $88.44 $7,021 - $9,905
-112 Reduced 0.31%
36,315 $2.75 Million
Q1 2022

May 13, 2022

BUY
$63.15 - $90.42 $122,258 - $175,053
1,936 Added 5.61%
36,427 $2.85 Million
Q4 2021

Feb 14, 2022

SELL
$77.28 - $99.42 $215,070 - $276,685
-2,783 Reduced 7.47%
34,491 $3.11 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $458,354 - $1.07 Million
6,344 Added 20.51%
37,274 $2.78 Million
Q4 2020

May 17, 2021

BUY
$125.56 - $178.74 $3.88 Million - $5.53 Million
30,930 New
30,930 $5.27 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.8B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.